ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE

<p>Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and...

Full description

Bibliographic Details
Main Authors: S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Klinicist
Subjects:
Online Access:http://klinitsist.abvpress.ru/index.php/Klin/article/view/125
_version_ 1797966462746361856
author S. Yu. Martsevich
N. P. Kutishenko
M. L. Ginzburg
A. M. Malysheva
Yu. N. Polyanskaya
author_facet S. Yu. Martsevich
N. P. Kutishenko
M. L. Ginzburg
A. M. Malysheva
Yu. N. Polyanskaya
author_sort S. Yu. Martsevich
collection DOAJ
description <p>Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and resistance was overcoming. Modern clinical guidelines on safe antiplatelet therapy are presented.</p>
first_indexed 2024-04-11T02:15:57Z
format Article
id doaj.art-3eda1d3b051444adb65f08a92e6ffc0b
institution Directory Open Access Journal
issn 1818-8338
language Russian
last_indexed 2024-04-11T02:15:57Z
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Klinicist
spelling doaj.art-3eda1d3b051444adb65f08a92e6ffc0b2023-01-03T01:06:03ZrusABV-pressKlinicist1818-83382014-07-01527279140ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCES. Yu. Martsevich0N. P. Kutishenko1M. L. Ginzburg2A. M. Malysheva3Yu. N. Polyanskaya4State Research Center for Preventive Medicine, Ministry of Health and Social Development of Russia I.M. Sechenov First Moscow State Medical UniversityState Research Center for Preventive Medicine, Ministry of Health and Social Development of RussiaLyubertsy District Hospital № 2, Moscow RegionState Research Center for Preventive Medicine, Ministry of Health and Social Development of RussiaState Research Center for Preventive Medicine, Ministry of Health and Social Development of Russia<p>Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and resistance was overcoming. Modern clinical guidelines on safe antiplatelet therapy are presented.</p>http://klinitsist.abvpress.ru/index.php/Klin/article/view/125antiplatelet agentsaspirinclopidogrelmyocardial infarctiondrug resistanceproton pump inhibitors
spellingShingle S. Yu. Martsevich
N. P. Kutishenko
M. L. Ginzburg
A. M. Malysheva
Yu. N. Polyanskaya
ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
Klinicist
antiplatelet agents
aspirin
clopidogrel
myocardial infarction
drug resistance
proton pump inhibitors
title ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
title_full ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
title_fullStr ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
title_full_unstemmed ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
title_short ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
title_sort antiplatelet therapy in patients with high risk of thrombotic events the problem of efficiency safety and compliance
topic antiplatelet agents
aspirin
clopidogrel
myocardial infarction
drug resistance
proton pump inhibitors
url http://klinitsist.abvpress.ru/index.php/Klin/article/view/125
work_keys_str_mv AT syumartsevich antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance
AT npkutishenko antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance
AT mlginzburg antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance
AT ammalysheva antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance
AT yunpolyanskaya antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance